Business Description
Neovasc Inc
NAICS : 339112
SIC : 3741
ISIN : CA64065J1066
Description
Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.98 | |||||
| Equity-to-Asset | 0.41 | |||||
| Debt-to-Equity | 0.82 | |||||
| Debt-to-EBITDA | -0.33 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -17.22 | |||||
| Beneish M-Score | -3.96 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -44.3 | |||||
| 3-Year EBITDA Growth Rate | 52.2 | |||||
| 3-Year EPS without NRI Growth Rate | 51.9 | |||||
| 3-Year FCF Growth Rate | 53.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | 350.15 | |||||
| 12-1 Month Momentum % | 198.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.96 | |||||
| Quick Ratio | 2.85 | |||||
| Cash Ratio | 2.56 | |||||
| Days Inventory | 614.94 | |||||
| Days Sales Outstanding | 102.28 | |||||
| Days Payable | 662.75 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -99.2 | |||||
| Shareholder Yield % | -7.64 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 79.63 | |||||
| Operating Margin % | -886.75 | |||||
| Net Margin % | -1082.92 | |||||
| FCF Margin % | -656.56 | |||||
| ROE % | -117.41 | |||||
| ROA % | -78.78 | |||||
| ROIC % | -309.62 | |||||
| ROC (Joel Greenblatt) % | -7331.05 | |||||
| ROCE % | -84.6 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 21.62 | |||||
| PB Ratio | 5.22 | |||||
| Price-to-Tangible-Book | 5.22 | |||||
| EV-to-EBIT | -1.79 | |||||
| EV-to-EBITDA | -1.8 | |||||
| EV-to-Revenue | 18.61 | |||||
| EV-to-Forward-Revenue | 7.28 | |||||
| EV-to-FCF | -2.83 | |||||
| Price-to-Median-PS-Value | 2.11 | |||||
| Price-to-Net-Current-Asset-Value | 12.01 | |||||
| Price-to-Net-Cash | 28.6 | |||||
| Earnings Yield (Greenblatt) % | -55.87 | |||||
| FCF Yield % | -30.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NVCN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Neovasc Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 3.805 | ||
| EPS (TTM) ($) | -15.08 | ||
| Beta | 0 | ||
| Volatility % | 120.8 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.212857 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 198.65 | ||
| 52-Week Range ($) | 4.585 - 30.07 | ||
| Shares Outstanding (Mil) | 2.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Neovasc Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Neovasc Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Neovasc Inc Frequently Asked Questions
What is Neovasc Inc(NVCN)'s stock price today?
The current price of NVCN is $30.03. The 52 week high of NVCN is $30.07 and 52 week low is $4.59.
When is next earnings date of Neovasc Inc(NVCN)?
The next earnings date of Neovasc Inc(NVCN) is .
Does Neovasc Inc(NVCN) pay dividends? If so, how much?
Neovasc Inc(NVCN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers